Osaic Holdings’s Cardio Diagnostics CDIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$31 Hold
16
﹤0.01% 7699
2025
Q4
$43 Sell
16
-73
-82% -$265 ﹤0.01% 7705
2025
Q3
$356 Sell
89
-18
-17% -$71 ﹤0.01% 7609
2025
Q2
$383 Sell
107
-96
-47% -$718 ﹤0.01% 7393
2025
Q1
$2.01K Buy
203
+40
+25% +$623 ﹤0.01% 6594
2024
Q4
$4.5K Buy
163
+58
+55% +$804 ﹤0.01% 6252
2024
Q3
$693 Hold
105
﹤0.01% 6946
2024
Q2
$1.73K Hold
105
﹤0.01% 6650
2024
Q1
$4.47K Buy
105
+88
+518% +$5.01K ﹤0.01% 6137
2023
Q4
$1.25K Buy
+17
New +$588 ﹤0.01% 6674

Other funds holding CDIO

Osaic Holdings's CDIO Position: Q1 2026 in Review

Osaic Holdings held its Cardio Diagnostics (CDIO) position steady in Q1 2026 at 16 shares worth $31. The position accounts for ﹤0.01% of the portfolio, ranked #7699.

Osaic Holdings first reported a position in CDIO in Q4 2023 and has held it in 10 quarters since. The position peaked at $4.5K in Q4 2024. 16 funds tracked by Wall St. Rank hold CDIO as of Q1 2026.

  • Osaic Holdings held 16 shares of Cardio Diagnostics worth $31 as of Q1 2026.
  • Osaic Holdings left its Cardio Diagnostics share count unchanged in Q1 2026.
  • Cardio Diagnostics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7699 holding.
  • Osaic Holdings first reported a position in Cardio Diagnostics in Q4 2023 and has held it in 10 quarters since.
  • Osaic Holdings's Cardio Diagnostics position peaked at $4.5K in Q4 2024.
  • 16 funds tracked by Wall St. Rank held Cardio Diagnostics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.